Independent review of trial event assessments by adjudication experts.
Proven expertise in delivering high-quality imaging data at a global scale.
With strengths in instrument engineering, signal processing, and pharmaceutical R&D, Perceptive Discovery consistently delivers successful imaging study designs and executions.
Effective RTSM, built on 30 years of experience, and connected to an ecosystem which includes eConsent and eCOA.
Highly established imaging centers for first-in-human and multicenter trials.
900+ agents radiolabeled and counting.
Supporting both malignant and non-malignant indications.
Experts in Alzheimer’s Disease, Parkinson’s Disease imaging and more.
Supporting over 85% of radiopharmaceutical companies.
Optimize preclinical and clinical trials in other areas and drug classifications.
Therapeutic and technical expertise in imaging modalities, protocol design, and acquisition.
Oncology imaging, RTSM, and clinical adjudication services.
Tackling unique rare disease trial supply, imaging and adjudication challenges.
Body composition imaging expertise you can rely on.
We are here to serve science.
From discovery, through early to late-phase clinical development, to regulatory approval and post-market, you can count on Perceptive to be dependable, diligent, and driven in everything we do.
Perceptive Discovery bridges preclinical insights to early clinical success, ensuring rigorous scientific analysis and high-quality data to support innovation.
Providing the right-fit randomization & trial supply management solution for your trials, delivered by experts.
The right people, experience, and technology to drive clinical trial imaging success.
Perceptive Imaging has defined its purpose as ‘Serving science to improve people’s lives.’ As such, we consider the rights, safety, and well-being of trial participants to be the most important aspect of quality criteria in our service delivery.
At Perceptive Imaging, quality control and quality assurance form an inherent part of our policies and procedures. This enables us to live up to our commitment to First Time Quality, as depicted in the image below (click to enlarge).
By following these well-defined processes, we enable quality by design with clearly defined preventative and detective controls, including:
Yes! At Perceptive, we not only expect regulatory agency inspections, we plan for them and are always ready. To date we have participated in:
Evidence of our approach to First Time Quality can be seen in the outcome of our customers’ important clinical development programs. In 2024, Perceptive Imaging data supported 42 regulatory approvals (313 total since 2002). These approvals were granted by various authorities including, but not limited to FDA, EMA, and NMPA.
Perceptive Imaging scientists and science operations teams have qualified imaging centers and sites across the globe. All Perceptive Imaging employees have a clear training plan and transcript.
They also have skills and experience that match their role. And we verify that independent reviewers have the required experience and expertise and are appropriately trained as part of trial onboarding.
Perceptive imaging has automated a variety of quality controls and we’re leveraging deterministic and self-learning AI solutions to proactively identify risks and potential concerns.
Reach out to better understand why Perceptive’s commitment to First Time Quality can make a difference in your clinical development program.
Reach out today and one of our solution experts will be in touch to learn about your specific needs.
"*" indicates required fields
Δ
